Functional Outcome After Mechanical Thrombectomy with or without Previous Thrombolysis.
Aged
Aged, 80 and over
Combined Modality Therapy
Databases, Factual
Disability Evaluation
Female
Fibrinolytic Agents
/ administration & dosage
Functional Status
Humans
Infusions, Intravenous
Ischemic Stroke
/ diagnosis
Male
Middle Aged
Recovery of Function
Retrospective Studies
Risk Factors
Thrombectomy
/ adverse effects
Thrombolytic Therapy
/ adverse effects
Time Factors
Time-to-Treatment
Treatment Outcome
Functional Outcome
Stroke
Thrombectomy
Thrombolysis
Journal
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
ISSN: 1532-8511
Titre abrégé: J Stroke Cerebrovasc Dis
Pays: United States
ID NLM: 9111633
Informations de publication
Date de publication:
Feb 2021
Feb 2021
Historique:
received:
22
09
2020
revised:
15
11
2020
accepted:
20
11
2020
pubmed:
15
12
2020
medline:
26
1
2021
entrez:
14
12
2020
Statut:
ppublish
Résumé
Combined intravenous therapy (IVT) and mechanical thrombectomy (MT) is the standard treatment for acute ischemic stroke (AIS) with large vessel occlusion (LVO). However, the use of IVT before MT is recently being questioned. To compare patients treated with IVT before MT with those treated with MT alone, in a real-world scenario. Retrospective analysis of AIS patients with LVO of the anterior circulation who underwent MT, with or without previous IVT, between 2016 and 2018. A total of 524 patients were included (347 submitted to IVT+MT; 177 to MT alone). No differences between groups were found except for a higher time from stroke onset to CT and to groin puncture in the MT group (297.5 min vs 115.0 min and 394.0 min vs 250.0 min respectively, p < 0.001). Multivariable analysis showed that age<75 years (OR 2.65, 95% CI 1.71-4.07, p < 0.001), not using antiplatelet therapy (OR 1.93, 95% CI 1.21-3.08, p = 0.006), low prestroke mRS (OR 4.33, 95% CI 1.89-9.89, p < 0.001), initial NIHSS (OR 0.89, 95% CI 0.86-0.93, p < 0.001), absent cerebral edema (OR 7.83, 95% CI 3.31-18.51, p < 0.001), and mTICI 2b/3 (OR 4.56, 95% CI 2.17-9.59, p < 0.001) were independently associated with good outcome (mRS 0-2). Our findings support the idea that IVT before MT does not influence prognosis, in a real-world setting.
Identifiants
pubmed: 33310592
pii: S1052-3057(20)30913-7
doi: 10.1016/j.jstrokecerebrovasdis.2020.105495
pii:
doi:
Substances chimiques
Fibrinolytic Agents
0
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
105495Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.